Reporter

Jonathan Saltzman

Jonathan Saltzman has worked at the Boston Globe since 2002 and currently covers biotechnology and the life sciences. He previously covered the federal and state courts and then spent six years on the Spotlight Team. He was part of a team that won a George Polk Award in 2012 for a series on the state’s unusually high rate of acquittal at bench trials for drunk driving. He was also a runner-up for other awards, including a Pulitzer Prize and Goldsmith Prize for Investigative Reporting, for a series of stories about dangerous off-campus housing for college students in Boston. Saltzman, a graduate of Brooklyn College, has worked at the Providence Journal, USA Today, the Rochester Democrat & Chronicle, and the Poughkeepsie Journal. He also co-hosted a daily magazine show for the NPR station in Rhode Island. He lives in Providence.

Latest stories

Moderna calls disagreements with government over COVID-19 vaccine ‘productive dialogue'

By , Globe Staff

The Cambridge biotech says it has resolved differences with federal agencies on how to run large clinical trials.

Cambridge biotech raises $110 million to advance treatment for blood cancer

By , Globe Staff

COVID-19 has upended the economy, but biotechs with promising medical treatments are still attracting venture capital.

Actual number of COVID-19 cases is 12 times higher than reported, with 50 percent more deaths, says MIT study

By , Globe Staff

The researchers contend that a swifter response to the pandemic could have prevented one-third of all fatalities.

For Boston Scientific, a ‘most difficult year’

By , Globe Staff

CEO Mike Mahoney, in his most detailed public remarks about how he is steering Boston Scientific through its biggest crisis since he became CEO in 2011, said the pandemic hasn’t been the only extraordinary challenge. The turmoil in Minneapolis also affected its employees.